Cargando…

1329. Vancomycin Therapeutic Drug Monitoring: How to hit the Curve

BACKGROUND: For the management of serious S. aureus infections, area-under-the curve to minimum inhibitory concentration (AUC/MIC) applied dosing is recommended as the preferred method to goal trough-based monitoring. This pharmacodynamic dosing demonstrates efficacy with optimized exposure and decr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vala, Michael, Chapin, Ryan, Mercuro, Nicholas J, McCoy, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777143/ http://dx.doi.org/10.1093/ofid/ofaa439.1511

Ejemplares similares

228. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
por: Li, Catherine, et al.
Publicado: (2020)

54. Microbiologic Characterization and Antibacterial Use in Hospitalized Adults with covid-19 Infection
por: Chapin, Ryan, et al.
Publicado: (2020)

666. Evaluation of Vancomycin Harms for Intra-abdominal Infections
por: McCoy, Christopher, et al.
Publicado: (2023)

P17 Vancomycin therapeutic drug monitoring—a call for change?
por: Payne, Lara, et al.
Publicado: (2022)

P1329: REGIONAL COMPARTMENTALIZATION OF THE BONE MARROW STROMA IS IMPORTANT FOR RESPONSES TO INFLAMMATION AND CANCER
por: Swann, James, et al.
Publicado: (2023)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

192. The Use of Area Under the Curve to Determine Therapeutic Vancomycin Dosing in Skin and Soft Tissue Infections
por: Dea, Lauren, et al.
Publicado: (2020)

1329. Experiences and Emotional Challenges of Antiretroviral Treatment (ART)—Findings from the Positive Perspectives Study
por: De Los Rios, Patricia, et al.
Publicado: (2019)

1329. Clinical Profile and Outcomes of Adults with Meningitis: A Prospective Observational Study from India
por: Sukhadiya, Pankaj, et al.
Publicado: (2023)

182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020)

2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
por: Viteri, Alina, et al.
Publicado: (2023)

1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Salazar, Luis W, et al.
Publicado: (2021)

1329 Impact of an antimicrobial order auto-stop on clinical outcomes at a single institution
por: Ross, Rachael, et al.
Publicado: (2014)

250 Dosing and therapeutic drug monitoring of intravenous vancomycin in cystic fibrosis: A practice survey
por: Dagenais, R., et al.
Publicado: (2022)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
por: Mason, P, et al.
Publicado: (2002)

1097. A Comparison of Area-Under Curve (AUC)-Guided vs Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-analysis
por: Lim, Ashley Shiyuan, et al.
Publicado: (2021)

Correction to Lancet Infect Dis 2022; 22: 1329–42
Publicado: (2022)

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
por: Dachy, F., et al.
Publicado: (2022)

1092. Impact of Relieving Infectious Diseases Fellows from Off-Hour/Weekend Antimicrobial Stewardship Coverage
por: Lee, Matthew S L, et al.
Publicado: (2019)

2793. Clinical Outcomes of Combination Therapy with Daptomycin and Ceftaroline for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Chapin, Ryan W, et al.
Publicado: (2023)

1096. Evaluation of Vancomycin Pharmacokinetics in Intravenous Drug Users
por: Weihs, Sayo, et al.
Publicado: (2021)

1871. Identifying Time Periods of High and Low Vancomycin Use
por: Liu, Jiajun, et al.
Publicado: (2018)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

329. Vancomycin area under the concentration-time curve monitoring from Bayesian modeling in outpatient parenteral antimicrobial therapy
por: Gillett, Eric M, et al.
Publicado: (2023)

Runs 1329 to 1332, 3.5 GeV/c Ring 2
por: Baird, S
Publicado: (1983)

Assessment of a Healthcare-Associated Pneumonia (HCAP) Risk Stratification and Empiric Treatment Guideline: A New Antimicrobial Stewardship Initiative
por: Chapin, Ryan, et al.
Publicado: (2017)

Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic
por: Li, Catherine, et al.
Publicado: (2021)

1329. Beyond Reporting: Using an Accreditation Council for Graduate Medical Education (ACGME) Milestone-Linked Evaluation System to Improve Clinical Infectious Diseases Rotations for Baylor College of Medicine Internal Medicine (BCM IM) Residents
por: Herrera, Lauren Nicholas, et al.
Publicado: (2018)

1326. Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
por: Pearson, Jeffrey, et al.
Publicado: (2020)

598. Area under the curve-guided vancomycin monitoring and risk of nephrotoxicity in non-Staphylococcus aureus infections: A case-control study
por: Mazewski, Douglas, et al.
Publicado: (2022)

164. Avoiding Complacency: Assessing the Perceived Impact and Value of Antimicrobial Stewardship at a Academic Medical Center
por: Lee, Matthew S, et al.
Publicado: (2020)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

Grading the Impact of a Standardized Β Lactam Antibiotic Allergy Assessment Protocol for Treatment Decisions: An Antimicrobial Stewardship Target
por: Hernandez, Kanizeh, et al.
Publicado: (2017)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

1108. Evaluation of Vancomycin Dosing in Adolescents
por: Weaver, Ashley I, et al.
Publicado: (2021)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

Vancomycin area under the curve-guided monitoring in pediatric patients
por: Morales Junior, Ronaldo, et al.
Publicado: (2022)

P1674: CLINICAL IMPACT OF NON-ADHERENCE TO HIT GUIDELINES: A DOUBLE HIT IN HIT
por: Al Raizah, A., et al.
Publicado: (2022)

1100. A Prospective Evaluation of Neurotoxicity Among Patients Receiving Dose-Optimized Cefepime or Meropenem With Concomitant Therapeutic Drug Monitoring
por: Smith, Brandon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4v7jqao7css4cmi1lqmst06g2f